2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Fungemia in 2 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
Fungemia: The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Villar-Vidal, M | 1 |
Marcos-Arias, C | 1 |
Eraso, E | 1 |
Quindós, G | 1 |
Pulcrano, G | 1 |
Panellis, D | 1 |
De Domenico, G | 1 |
Rossano, F | 1 |
Catania, MR | 1 |
2 other studies available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Fungemia
Article | Year |
---|---|
Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.
Topics: Aerobiosis; Biofilms; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Fungemia; Humans; O | 2011 |
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Micro | 2012 |